Hospital
Norcal Healthconnect LLC
Norcal Healthconnect LLC was paid $4.58M by Medicaid between Sep 2022 and Nov 2024, across 91 billing codes. Its largest line is 99281, Emergency department visit for the evaluation and management, self-limited or minor — 37% of everything it billed.
33Billing provider infoNORCAL HEALTHCONNECT LLC
HEALDSBURG, CA 95448
HEALDSBURG, CA 95448
33aNPI1861009672assigned 09/25/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.58M
24GClaims49,592
24DCodes billed91
24AFirst – last monthSep 2022 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#231 of 410
Median peer was paid$6.90M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 7,554 | $684K | |
| 2023 | 24,815 | $2.22M | |
| 2024incomplete | 17,223 | $1.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 37% | 8,743 | 7,677 | $1.70M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 6,146 | 5,020 | $580K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 8.3% | 2,323 | 1,848 | $380K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.5% | 2,892 | 1,048 | $344K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.7% | 861 | 801 | $168K |
| 97750 | 3.6% | 1,114 | 571 | $166K | |
| 93976 | 2.1% | 115 | 114 | $98K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.0% | 972 | 897 | $89K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 688 | 639 | $87K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.9% | 247 | 243 | $87K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.7% | 858 | 823 | $78K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 793 | 720 | $72K |
79 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 876 | $71K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 63 | $50K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 101 | $44K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 171 | $43K |
| 71045 | Radiologic examination, chest; single view | <1% | 763 | $30K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 78 | $29K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 29 | $29K |
| 73562 | <1% | 341 | $29K | |
| J3490 | Unclassified drugs | <1% | 3,933 | $26K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 105 | $24K |
| 80053 | Comprehensive metabolic panel | <1% | 2,137 | $20K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 557 | $17K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 86 | $17K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 134 | $17K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 64 | $17K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,334 | $16K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 384 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 72 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 223 | $14K |
| Q3014 | Telehealth originating site facility fee | <1% | 140 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 327 | $13K |
| Z7502 | <1% | 345 | $13K | |
| 99070 | <1% | 837 | $12K | |
| 73110 | <1% | 126 | $12K | |
| 73030 | <1% | 117 | $11K | |
| 81001 | <1% | 1,095 | $10K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 128 | $10K |
| 73130 | <1% | 96 | $9K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 201 | $9K |
| 84484 | <1% | 707 | $7K | |
| 83690 | <1% | 999 | $6K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 190 | $6K |
| 76830 | Ultrasound, transvaginal | <1% | 25 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 998 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 109 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 67 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 614 | $5K |
| 73610 | <1% | 44 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 833 | $4K |
| 73630 | <1% | 44 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 147 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 29 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $2K |
| 76801 | <1% | 12 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 58 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 250 | $2K |
| 81025 | <1% | 577 | $2K | |
| 0450 | Emergency room services | <1% | 33 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 240 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 175 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 179 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 131 | $915.67 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 127 | $851.36 |
| 83880 | <1% | 32 | $771.84 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | $748.08 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 160 | $728.81 |
| 73140 | <1% | 12 | $708.48 | |
| 80305 | <1% | 68 | $680.96 | |
| 81003 | <1% | 319 | $611.25 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 61 | $606.48 |
| 82150 | <1% | 112 | $590.54 | |
| 90715 | <1% | 12 | $513.24 | |
| 83605 | <1% | 46 | $421.57 | |
| 82962 | <1% | 161 | $381.28 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 62 | $305.89 |
| 87077 | <1% | 42 | $261.26 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 16 | $211.75 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 12 | $208.46 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 36 | $199.65 |
| 96127 | <1% | 15 | $188.31 | |
| 87040 | <1% | 23 | $172.32 | |
| Z7610 | <1% | 21 | $157.89 | |
| 87070 | <1% | 15 | $151.31 | |
| 85610 | <1% | 44 | $141.79 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 26 | $140.70 |
| 87081 | <1% | 17 | $96.56 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 12 | $90.53 |
| 87205 | <1% | 15 | $70.01 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 13 | $11.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.